Product Strategy — Company Profile

Overview

European IVF centres, targeting measurable improvement in live birth rates per transfer as the primary differentiation lever against commodity catheter alternatives. IVF cycle volumes are insufficient to justify premium consumable procurement; strategy focuses on bundled pricing with embryo transfer catheters to increase wallet share per clinic account. Gynetics is leveraging this clinical trend to expand placement of diagnostic catheters as a gateway to full embryo transfer catheter adoption.

Table of Contents

• Company Overview & Strategy
• Financial Performance (2022–2024)
• Product Portfolio
• SWOT Analysis